| Literature DB >> 29410129 |
Takuo Hayashi1, Kazuya Takamochi2, Yuka Yanai3, Keiko Mitani3, Hisashi Tomita2, Kaoru Mogushi4, Yoshiyuki Suehara5, Fumiyuki Takahashi6, Kenji Suzuki2, Tsuyoshi Saito3, Takashi Yao3.
Abstract
Here, we present a case of non-small cell lung carcinoma (NSCLC) with widespread and strong nuclear immunopositivity for both thyroid transcription factor-1 (TTF-1) and ΔNp63/p40 (p40). Double immunofluorescence for TTF-1 and p40 showed coexpression of both markers in the tumor cells. Furthermore, PTEN (pHis123Asp) and TP53 (pVal272Leu) mutations were identified as possible mitogenic driver mutations by next-generation sequencing. To the best of our knowledge, this is the first case of NSCLC harboring concurrent PTEN and TP53 mutations with widespread and strong coexpression of TTF-1 and p40, which has been confirmed in the resected specimen, and only the second documented case of NSCLC with TTF-1 and p40 diffuse coexpression in the carcinoma cells from the same individual. Our case illustrates the possibility that poorly differentiated NSCLCs with widespread and strong nuclear positivity for TTF-1 and p40 may be an underrecognized and new entity.Entities:
Keywords: Lung adenocarcinoma; Lung squamous cell carcinoma; Next-generation sequencing; TTF-1; p40
Mesh:
Substances:
Year: 2018 PMID: 29410129 DOI: 10.1016/j.humpath.2018.01.023
Source DB: PubMed Journal: Hum Pathol ISSN: 0046-8177 Impact factor: 3.466